BioCT welcomes new member CPS Fluidics
CPS Fluidics provides engineering and manufacturing services of custom microfluidics and consumable devices for the life sciences and biotechnology markets. CPS Fluidics highly values client partnerships,...
Home >
Access the latest news, business developments, company updates, industry trends, events and more.
CPS Fluidics provides engineering and manufacturing services of custom microfluidics and consumable devices for the life sciences and biotechnology markets. CPS Fluidics highly values client partnerships,...
Pfizer’s 20-valent pneumococcal conjugate vaccine has taken a step toward approval in infants. After four doses, all 20 serotypes met the statistical noninferiority criteria in...
UConn has launched a new multidisciplinary Master’s in Data Science program and an inaugural full-time cohort of 20 students starting in the upcoming Fall 2022 semester....
CONMED Corporation has entered into an agreement to acquire New Haven-based medical technology company Biorez. Biorez is known for its FDA-approved BioBrace implant technology. The...
Thermo Fisher Scientific has completed an expansion at its dry powder media manufacturing plant, expanding the site’s production arsenal to include technology and materials used in...
View this email in your browser Weekly Roundup – August 11, 2022 FML recently published an article in TechCrunch explaining convertible notes for startups. Julie Gionfriddo, Director, Advisory...
BioCT welcomes Josh Geballe, MBA, to its Board of Directors Josh is Senior Associate Provost for Entrepreneurship and Innovation at Yale University and Managing Director of Yale...
Pfizer has agreed to acquire Global Blood Therapeutics, a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved...
View this email in your browser Career News – August 9, 2022 Alexion Director, CMC Team Lead New Haven Associate Director, Biostatistics New Haven +72 more Arvinas ...
EvolveImmune Therapeutics has appointed Jay S. Fine, Ph.D., as the company’s President of Research and Development. Dr. Fine is an accomplished biopharmaceutical executive with a successful...